WebIts products under developmenBaudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the … WebDec 17, 2024 · MALVERN, Pa., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ: BXRX ), a pharmaceutical company focused on therapeutics for acute care settings, (“Baudax Bio” or the “Company”) today...
Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary
WebPart 2 has now been initiated. Pulmatrix, Inc. (NASDAQ: PULM) announced a 1-for-20 reverse split of its stock on February 28, 2024. Ocugen (NASDAQ: OCGN) reported … WebJan 24, 2024 · Baudax Bio Announces Pricing of $5 Million Public Offering. View Press Release. Nov 30, 2024 • 4:50 PM EST. Baudax Bio Announces 1-for-40 Reverse Stock Split. View Press Release. Nov 8, 2024 • 4:09 PM EST. Baudax Bio Reports Third Quarter 2024 Financial Results and Business Highlights. freight oocl
2024-08-29 NDAQ:BXRX Press Release Baudax Bio Inc.
WebBXRX Complete Baudax Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebFeb 8, 2024 · H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to Baudax Bio from the offering are expected to be approximately $17.6 million. WebDec 28, 2024 · MALVERN, Pa., Dec. 28, 2024 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that it has entered into a definitive agreement with certain institutional investors for the issuance … freight on sales hsn code